These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 28488784)

  • 1. CT-determined pulmonary artery to aorta ratio as a predictor of elevated pulmonary artery pressure and survival in idiopathic pulmonary fibrosis.
    Yagi M; Taniguchi H; Kondoh Y; Ando M; Kimura T; Kataoka K; Furukawa T; Suzuki A; Johkoh T; Hasegawa Y
    Respirology; 2017 Oct; 22(7):1393-1399. PubMed ID: 28488784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary hypertension as a prognostic indicator at the initial evaluation in idiopathic pulmonary fibrosis.
    Kimura M; Taniguchi H; Kondoh Y; Kimura T; Kataoka K; Nishiyama O; Aso H; Sakamoto K; Hasegawa Y
    Respiration; 2013; 85(6):456-63. PubMed ID: 23257350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A scoring system to predict the elevation of mean pulmonary arterial pressure in idiopathic pulmonary fibrosis.
    Furukawa T; Kondoh Y; Taniguchi H; Yagi M; Matsuda T; Kimura T; Kataoka K; Johkoh T; Ando M; Hashimoto N; Sakamoto K; Hasegawa Y
    Eur Respir J; 2018 Jan; 51(1):. PubMed ID: 29348178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis.
    Shin S; King CS; Puri N; Shlobin OA; Brown AW; Ahmad S; Weir NA; Nathan SD
    Eur Respir J; 2016 May; 47(5):1445-51. PubMed ID: 26846836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.
    Alkukhun L; Wang XF; Ahmed MK; Baumgartner M; Budev MM; Dweik RA; Tonelli AR
    Respir Med; 2016 Aug; 117():65-72. PubMed ID: 27492515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between pulmonary artery to aorta diameter ratio with pulmonary hypertension and outcomes in diffuse cystic lung diseases.
    Baldi BG; Fernandes CJCDS; Heiden GI; Freitas CSG; Sobral JB; Kairalla RA; Carvalho CRR; Souza R
    Medicine (Baltimore); 2021 Jun; 100(25):e26483. PubMed ID: 34160461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension due to left heart disease: diagnostic and prognostic value of CT in chronic systolic heart failure.
    Colin GC; Gerber BL; de Meester de Ravenstein C; Byl D; Dietz A; Kamga M; Pasquet A; Vancraeynest D; Vanoverschelde JL; D'Hondt AM; Ghaye B; Pouleur AC
    Eur Radiol; 2018 Nov; 28(11):4643-4653. PubMed ID: 29761362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fraction.
    Karakus G; Kammerlander AA; Aschauer S; Marzluf BA; Zotter-Tufaro C; Bachmann A; Degirmencioglu A; Duca F; Babayev J; Pfaffenberger S; Bonderman D; Mascherbauer J
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):79. PubMed ID: 26318496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the combination of echo-HRCT score as a tool to evaluate the presence of pulmonary hypertension in idiopathic pulmonary fibrosis.
    Refini RM; Bettini G; Kacerja E; Cameli P; d'Alessandro M; Bergantini L; De Negri F; Rottoli P; Sestini P; Bargagli E; Mazzei MA
    Intern Emerg Med; 2021 Jun; 16(4):941-947. PubMed ID: 33151480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular parameters of chest CT scan in estimating pulmonary arterial pressure in patients with pulmonary hypertension.
    Li M; Wang S; Lin W; Li J; Wang C; Chen H; Lu W; Yang K; Wang J; Zeng Q
    Clin Respir J; 2018 Feb; 12(2):572-579. PubMed ID: 27696745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimodal noninvasive prediction of pulmonary hypertension in IPF.
    Sonti R; Gersten RA; Barnett S; Brown AW; Nathan SD
    Clin Respir J; 2019 Sep; 13(9):567-573. PubMed ID: 31301257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A four-tier classification system of pulmonary artery metrics on computed tomography for the diagnosis and prognosis of pulmonary hypertension.
    Truong QA; Bhatia HS; Szymonifka J; Zhou Q; Lavender Z; Waxman AB; Semigran MJ; Malhotra R
    J Cardiovasc Comput Tomogr; 2018; 12(1):60-66. PubMed ID: 29254655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of diffuse pulmonary fibrosis on the reliability of CT signs of pulmonary hypertension.
    Devaraj A; Wells AU; Meister MG; Corte TJ; Hansell DM
    Radiology; 2008 Dec; 249(3):1042-9. PubMed ID: 19011195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination.
    Devaraj A; Wells AU; Meister MG; Corte TJ; Wort SJ; Hansell DM
    Radiology; 2010 Feb; 254(2):609-16. PubMed ID: 20093532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD.
    Oki Y; Kaneko M; Fujimoto Y; Sakai H; Misu S; Mitani Y; Yamaguchi T; Yasuda H; Ishikawa A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2869-2875. PubMed ID: 27920514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hypertension in chronic lung diseases.
    Seeger W; Adir Y; Barberà JA; Champion H; Coghlan JG; Cottin V; De Marco T; Galiè N; Ghio S; Gibbs S; Martinez FJ; Semigran MJ; Simonneau G; Wells AU; Vachiéry JL
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D109-16. PubMed ID: 24355635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry.
    Swift AJ; Rajaram S; Hurdman J; Hill C; Davies C; Sproson TW; Morton AC; Capener D; Elliot C; Condliffe R; Wild JM; Kiely DG
    JACC Cardiovasc Imaging; 2013 Oct; 6(10):1036-1047. PubMed ID: 23769494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right Ventricular Structure and Function in Idiopathic Pulmonary Fibrosis with or without Pulmonary Hypertension.
    D'Andrea A; Stanziola A; Di Palma E; Martino M; D'Alto M; Dellegrottaglie S; Cocchia R; Riegler L; Betancourt Cordido MV; Lanza M; Maglione M; Diana V; Calabrò R; Russo MG; Vannan M; Bossone E
    Echocardiography; 2016 Jan; 33(1):57-65. PubMed ID: 26096076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of Mean, Diastolic, and Systolic Pulmonary Artery Pressure in Patients With End-stage Lung Disease Referred for Lung Transplantation.
    Nowak J; Hudzik B; Przybyłowski P; Niedziela J; Walczak P; Rozentryt P; Ochman M; Żegleń S; Wojarski J; Zembala M; Gąsior M
    Transplant Proc; 2018 Sep; 50(7):2048-2052. PubMed ID: 30177107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary hypertension due to left heart disease: diagnostic value of pulmonary artery distensibility.
    Colin GC; Verlynde G; Pouleur AC; Gerber BL; Beauloye C; Kefer J; Coche E; Vachiéry JL; Gevenois PA; Ghaye B
    Eur Radiol; 2020 Nov; 30(11):6204-6212. PubMed ID: 32548647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.